Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)

被引：0
|
作者：
Z. Wang
Z. Zhao
Y. Xia
Z. Cai
C. Wang
Y. Shen
R. Liu
H. Qin
J. Jia
G. Yuan
机构：
[1] Affiliated Hospital of Jiangsu University,Department of Endocrinology
来源：
Journal of Endocrinological Investigation | 2022年 / 45卷
关键词：
WGCNA; Single-cell RNA-seq; NASH; Fibrosis; HCC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1379 / 1392
页数：13
相关论文
共 50 条
  • [1] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Wang, Z.
    Zhao, Z.
    Xia, Y.
    Cai, Z.
    Wang, C.
    Shen, Y.
    Liu, R.
    Qin, H.
    Jia, J.
    Yuan, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (07) : 1379 - 1392
  • [2] Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
    Qi, Xiaoyan
    Lai, Jinping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [3] Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH)
    Ure, Daren R.
    Trepanier, Daniel J.
    Mayo, Patrick R.
    Foster, Robert T.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (02) : 163 - 178
  • [4] Phosphoproteomic Biomarkers Predicting Histologic Nonalcoholic Steatohepatitis and Fibrosis
    Younossi, Zobair M.
    Baranova, Ancha
    Stepanova, Maria
    Page, Sandra
    Calvert, Valerie S.
    Afendy, Arian
    Goodman, Zachary
    Chandhoke, Vikas
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (06) : 3218 - 3224
  • [5] Predicting nonalcoholic steatohepatitis (NASH) using mechanistic biomarkers
    Tan, Eunice
    Jumat, Nur Halisa
    Soon, Gwyneth Shook Ting
    Lee, Jonathan Wei Jie
    Dan, Yock Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 425 - 425
  • [6] Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
    Wattacheril, Julia
    Issa, Danny
    Sanyal, Arun
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58, 2018, 58 : 649 - 662
  • [7] NASH - Nonalcoholic steatohepatitis
    Blechacz, B
    Stremmel, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (01): : 77 - 90
  • [8] The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis
    Ralf Weiskirchen
    Frank Tacke
    Current Hepatology Reports, 2018, 17 (4) : 324 - 335
  • [9] Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
    Caussy, Cyrielle
    Chuang, Jen-Chieh
    Billin, Andrew
    Hu, Tao
    Wang, Ya
    Subramanian, G. Mani
    Djedjos, C. Stephen
    Myers, Robert P.
    Dennis, Edward A.
    Loomba, Rohit
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [10] Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice
    Rajak, Sangam
    Tewari, Archana
    Raza, Sana
    Gupta, Pratima
    Chakravarti, Bandana
    Anjum, Baby
    Tripathi, Madhulika
    Singh, Brijesh K.
    Yen, Paul M.
    Goel, Amit
    Ghosh, Sujoy
    Sinha, Rohit A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (04):
12345